Skip to main content
. Author manuscript; available in PMC: 2020 Aug 18.
Published in final edited form as: J Med Genet. 2011 Feb 15;48(4):266–272. doi: 10.1136/jmg.2010.086538

Table 4.

Estimates of hazard ratios and age-specific cumulative risk of melanoma from birth, for carriers of a CDKN2A mutation, by region and sex

Age-specific cumulative risk % (95% CI) for mutation carriers
Geographic region
and sex
Hazard ratio1
(95% CI)
To age 40 To age 50 To age 60 To age 70 To age 80
United Kingdom
 All 87 (50-153) 9 (5-15) 16 (10-27) 26 (16-41) 35 (22-53) 45 (29-65)
 Females 78 (33-181) 11 (5-23) 20 (9-40) 29 (14-55) 37 (18-66) 45 (23-75)
 Males 98 (44-215) 7 (3-15) 13 (6-26) 23 (11-43) 33 (16-58) 45 (24-73)
Australia
 All 31 (20-50) 11 (7-17) 20 (13-30) 30 (20-44) 41 (28-57) 52 (37-69)
 Females 48 (25-89) 19 (11-33) 33 (19-52) 44 (26-66) 53 (33-76) 64 (42-85)
 Males 18 (8-41) 5 (3-12) 11 (5-23) 19 (9-37) 29 (14-53) 38 (19-66)
 Brisbane 9 (2-33) 4 (1-15) 9 (3-29) 14 (4-44) 21 (6-57) 28 (9-70)
 Sydney 44 (22-88) 14 (7-26) 24 (13-43) 35 (19-58) 47 (27-72) 57 (35-82)
 Melbourne 49 (24-98) 15 (8-28) 24 (13-43) 36 (20-59) 47 (27-72) 58 (35-83)

CI = confidence interval

1

Hazard ratio for melanoma for mutation carriers compared to the general population. P-values for hazard ratio differences between subgroups are: UK all versus Australia all: 0.008; UK females versus UK males: 0.20; Australian females versus Australian males: 0.07; Brisbane versus Sydney versus Melbourne: 0.02